Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 17.2% in the ...

New hope for 10x’ preliminary injunction after EPO Opposition Division ruling | Patent at issue concerns single-cell spatial ...

Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...

CMC Invest offers 2 free trades per month for Singapore stocks for base Gold Tier. Its Platinum Tier and Diamond Tier have fixed monthly charges of $48 and $128 respectively, but incur lower brokerage ...

2 Reasons to Sell TXG and 1 Stock to Buy Instead What a brutal six months it’s been for 10x Genomics. The stock has dropped 52.1% and now trades at $10.59, rattling many shareholders. This was ...

“What Biopeak is doing is again very cutting edge because in conscious medicine, there are things that you can do in the US, and there are things that you can do in Singapore ... with respect to ...

22/07/2011 Agilent Technologies Inc. SANTA CLARA, Calif., and SINGAPORE, July 20, 2011 - Agilent Technologies Inc. (NYSE: A) today announced that Molecular Genomics is the newest Agilent Certified ...

Securities.io is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Trading involves risk which ...

Amy Danise is the managing editor for the insurance section at Forbes Advisor, which encompasses auto, home, renters, life, pet, travel, health and small business insurance. She is a highly ...

10x Genomics has a fifty-two week low of $9.77 and a fifty-two week high of $45.60. The firm’s 50 day moving average price is $13.90 and its 200 day moving average price is $16.67. Get 10x ...